Yvonne Li
2024
In 2024, Yvonne Li earned a total compensation of $547.5K as Interim Chief Financial Officer at Senti Biosciences.
Compensation breakdown
| Other | $547,540 |
|---|---|
| Total | $547,540 |
Li received $547.5K in other compensation, accounting for 100% of the total pay in 2024.
Rankings
In 2024, Yvonne Li's compensation ranked 135th out of 244 executives tracked by ExecPay. In other words, Li earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 135 out of 244 | 45th |
Division Manufacturing | 58 out of 108 | 46th |
Major group Chemicals And Allied Products | 24 out of 44 | 46th |
Industry group Drugs | 24 out of 41 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 4 out of 6 | 33rd |
Source: SEC filing on January 27, 2025.
Li's colleagues
We found two more compensation records of executives who worked with Yvonne Li at Senti Biosciences in 2024.